103 related articles for article (PubMed ID: 21744523)
1. Hospital in the home.
Montalto M
Aust Fam Physician; 2011 Apr; 40(4):183, 185. PubMed ID: 21744523
[No Abstract] [Full Text] [Related]
2. Prognosis on chronic dobutamine or milrinone infusions for stage D heart failure.
Gorodeski EZ; Chu EC; Reese JR; Shishehbor MH; Hsich E; Starling RC
Circ Heart Fail; 2009 Jul; 2(4):320-4. PubMed ID: 19808355
[TBL] [Abstract][Full Text] [Related]
3. Should we use outpatient dobutamine or milrinone?
Kato M; Sanada S; Kitakaze M
Circ Heart Fail; 2009 Jul; 2(4):377-8. PubMed ID: 19808362
[No Abstract] [Full Text] [Related]
4. [Combination therapy; dobutamine and milrinone].
Kato M; Hirayama A
Nihon Rinsho; 2011 Nov; 69 Suppl 9():428-33. PubMed ID: 22724242
[No Abstract] [Full Text] [Related]
5. Outpatient continuous inotrope infusion as an adjunct to heart failure therapy in Duchenne muscular dystrophy.
Cripe LH; Barber BJ; Spicer RL; Wong BL; Weidner N; Benson DW; Markham LW
Neuromuscul Disord; 2006 Nov; 16(11):745-8. PubMed ID: 17005398
[TBL] [Abstract][Full Text] [Related]
6. Need for hospice and palliative care services in patients with end-stage heart failure treated with intermittent infusion of inotropes.
López-Candales AL; Carron C; Schwartz J
Clin Cardiol; 2004 Jan; 27(1):23-8. PubMed ID: 14743852
[TBL] [Abstract][Full Text] [Related]
7. In-hospital mortality in patients with acute decompensated heart failure requiring intravenous vasoactive medications: an analysis from the Acute Decompensated Heart Failure National Registry (ADHERE).
Abraham WT; Adams KF; Fonarow GC; Costanzo MR; Berkowitz RL; LeJemtel TH; Cheng ML; Wynne J; ;
J Am Coll Cardiol; 2005 Jul; 46(1):57-64. PubMed ID: 15992636
[TBL] [Abstract][Full Text] [Related]
8. Intravenous heart failure medications: an update for home health clinicians.
Sherrod MM; Graulty R; Crawford M; Cheek DJ
Home Healthc Nurse; 2009; 27(10):610-9; quiz 620-1. PubMed ID: 19907237
[TBL] [Abstract][Full Text] [Related]
9. Effects of intravenous home dobutamine in palliative end-stage heart failure on quality of life, heart failure hospitalization, and cost expenditure.
Martens P; Vercammen J; Ceyssens W; Jacobs L; Luwel E; Van Aerde H; Potargent P; Renaers M; Dupont M; Mullens W
ESC Heart Fail; 2018 Aug; 5(4):562-569. PubMed ID: 29341466
[TBL] [Abstract][Full Text] [Related]
10. Positive inotropic drug infusions for patients with heart failure: current controversies and best practice.
Gorski LA
Home Healthc Nurse; 2002 Apr; 20(4):244-53; quiz 253-4. PubMed ID: 11984193
[TBL] [Abstract][Full Text] [Related]
11. Predictors of clinical outcome in advanced heart failure patients on continuous intravenous milrinone therapy.
Bhat G
ASAIO J; 2006; 52(6):677-81. PubMed ID: 17117058
[TBL] [Abstract][Full Text] [Related]
12. The cul-de-sac at the end of the road.
Stevenson LW
J Card Fail; 2003 Jun; 9(3):188-91. PubMed ID: 12815568
[No Abstract] [Full Text] [Related]
13. Effects of standard heart failure therapy and concomitant treatment with intravenous furosemide or inotropes (dobutamine, dopamine, and/or milrinone) on renal function and mortality in patients treated with nesiritide.
Kurien S; Warfield KT; Wood CM; Miller WL
Am J Cardiol; 2006 Dec; 98(12):1627-30. PubMed ID: 17145223
[TBL] [Abstract][Full Text] [Related]
14. Home continuous positive inotropic infusion as a bridge to cardiac transplantation in patients with end-stage heart failure.
Upadya S; Lee FA; Saldarriaga C; Verma S; Sedrakyan A; Nystrom K; Katz SD
J Heart Lung Transplant; 2004 Apr; 23(4):466-72. PubMed ID: 15063407
[TBL] [Abstract][Full Text] [Related]
15. Use of intravenous inotropic therapy in the home.
McCloskey WW
Am J Health Syst Pharm; 1998 May; 55(9):930-5; quiz 953-4. PubMed ID: 9588252
[TBL] [Abstract][Full Text] [Related]
16. Canadian Palliative Community Milrinone Infusions: A Case Series.
Reimche R; Salcedo D
Can J Cardiovasc Nurs; 2016; 26(1):9-13. PubMed ID: 27159935
[TBL] [Abstract][Full Text] [Related]
17. Home inotropic therapy in children.
Berg AM; Snell L; Mahle WT
J Heart Lung Transplant; 2007 May; 26(5):453-7. PubMed ID: 17449413
[TBL] [Abstract][Full Text] [Related]
18. Ambulatory Intravenous Inotropic Support and or Levosimendan in Pediatric and Congenital Heart Failure: Safety, Survival, Improvement, or Transplantation.
Apostolopoulou SC; Vagenakis GA; Tsoutsinos A; Kakava F; Rammos S
Pediatr Cardiol; 2018 Oct; 39(7):1315-1322. PubMed ID: 29777282
[TBL] [Abstract][Full Text] [Related]
19. Continuous Cardiac Inotropes in Patients With End-Stage Heart Failure: An Evolving Experience.
Malotte K; Saguros A; Groninger H
J Pain Symptom Manage; 2018 Jan; 55(1):159-163. PubMed ID: 29030210
[TBL] [Abstract][Full Text] [Related]
20. [Additive effects of milrinone and dobutamine in severe heart failure].
Meissner A; Herrmann G; Gerdesmeyer L; Simon R
Z Kardiol; 1992 May; 81(5):266-71. PubMed ID: 1621407
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
